Drug Database
RE
recombinant human insulin (insulin, HEC Pharm)
✓ ApprovedHEC Pharm · INSR · Recombinant Proteins
What is recombinant human insulin?
recombinant human insulin is a recombinant proteins developed by HEC Pharm. It is approved for therapeutic indications via injectable (others) or subcutaneous injection.
Drug Profile
| Brand Names | insulin, HEC Pharm |
| Company | HEC Pharm |
| Drug Class | Recombinant Proteins |
| Molecular Target | INSR |
| Route | Injectable (Others), Subcutaneous Injection |
| Status | Approved |
Sources: ClinicalTrials.gov, HEC Pharm
Mechanism of Action
Molecular Targets
recombinant human insulin acts on 1 molecular target:
| INSR | insulin receptor (CD220, HHF5) |
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.
Therapeutic Indications
recombinant human insulin is developed for 2 unique indications across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Metabolism and nutrition disorders | Type 1 diabetes mellitus | ✓ Approved |
| Metabolism and nutrition disorders | Type 2 diabetes mellitus | ✓ Approved |
Related Research Articles
Unable to load articles right now.